Market Overview:
The global bio-banking human samples market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for human samples for biotherapy and research institutions applications. Additionally, the growing population base is also contributing to the growth of this market. However, stringent regulatory norms and lack of awareness are some of the major factors restraining the growth of this market. Based on type, population-based biobanks accounted for a larger share in 2017 and is expected to maintain its dominance during the forecast period as well.
Product Definition:
Bio-banking is the process of collecting, storing, and distributing biological samples. These samples can include tissues, cells, blood, DNA, and other body fluids. Bio-banks are important for many reasons. They allow researchers to study diseases and develop new treatments. They also help doctors diagnose illnesses and choose the best treatment for their patients.
Population Based Biobank:
A population based biobank is a bank that collects biological samples from individuals and stores them for future study. The main purpose of such bank is to gather genetic material from a large number of people to understand the human genome better. It also helps in studying various diseases, thus improving healthcare facilities by providing data on how certain diseases are passed on genetically.
Disease-Oriented Biobank:
A disease-oriented biobank is a bank that collects biological samples from patients with specific diseases or health conditions for the purpose of research and development. The samples are collected, processed, and stored under controlled conditions for future use by researchers. Disease-oriented biobanks have been in practice since the early 20th century; however, they were not called that until recently. They used to be known as blood banks or tissue banks (depending upon the type of sample being collected).
Application Insights:
The biotherapy segment dominated the global bio-banking human samples market in terms of revenue share in 2017. This is due to an increase in the adoption of advanced therapies for various chronic diseases, such as cancer and diabetes. For instance, according to a study published by NCBI, around 60% of clinical trials are conducted using blood samples from healthy individuals for drug development. Therefore, there is a high demand for banking these types of samples so that they can be used during future research projects on patients suffering from chronic diseases.
On the other hand, population based biobanks collect biological materials from healthy individuals and store them safely so that researchers can access them when needed for conducting studies related to disease etiology or prevention.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. This is due to the presence of a large number of biobanks that store blood and tissue samples from individuals with chronic diseases, such as cancer, HIV/AIDS, diabetes, and arthritis. The U.S.-based Biobankof Washington stores biosamples from more than 300 patients while the UK’s Biobank has stored biosamples from over 500 people with various conditions including cancer, Parkinson's disease and Alzheimer's disease among others (Hancock et al., 2016). Thus far these banks have contributed immensely to research activities by making available a large pool of human samples for biomedical research studies across North America.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to an increase in government initiatives for setting up bio-banks across this region coupled with growing awareness about advanced banking techniques among researchers & clinicians operating within this region (Kumar & Srivastava., 2014).
Growth Factors:
- Increasing demand for personalized medicines and therapies
- Growing prevalence of chronic diseases
- Technological advancements in bio-banking field
- Proliferation of private biobanks
- Stringent regulatory framework for bio-banking
Scope Of The Report
Report Attributes
Report Details
Report Title
Bio-Banking Human Samples Market Research Report
By Type
Population Based Biobank, Disease-Oriented Biobank
By Application
Biotherapy, Research Institutions
By Companies
Brooks Life Science, Tecan Group, Promega, Hamilton, BD, Merck, DNA Genotek, Biolife Solutions, QIAGEN, Greiner Bio One, Shanghai Genext Medical Techology Co Ltd, TTP Labtech Ltd, BioRep, Beckman Coulter
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
199
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Bio-Banking Human Samples Market Report Segments:
The global Bio-Banking Human Samples market is segmented on the basis of:
Types
Population Based Biobank, Disease-Oriented Biobank
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biotherapy, Research Institutions
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Brooks Life Science
- Tecan Group
- Promega
- Hamilton
- BD
- Merck
- DNA Genotek
- Biolife Solutions
- QIAGEN
- Greiner Bio One
- Shanghai Genext Medical Techology Co Ltd
- TTP Labtech Ltd
- BioRep
- Beckman Coulter
Highlights of The Bio-Banking Human Samples Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Population Based Biobank
- Disease-Oriented Biobank
- By Application:
- Biotherapy
- Research Institutions
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bio-Banking Human Samples Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bio-banking is the process of collecting and storing human biological samples for future research. Samples can be collected from patients during medical procedures, such as blood draws or tissue biopsies, or they can be collected from individuals who volunteer for research studies.
Some of the major companies in the bio-banking human samples market are Brooks Life Science, Tecan Group, Promega, Hamilton, BD, Merck, DNA Genotek, Biolife Solutions, QIAGEN, Greiner Bio One, Shanghai Genext Medical Techology Co Ltd, TTP Labtech Ltd, BioRep, Beckman Coulter.
The bio-banking human samples market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bio-Banking Human Samples Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bio-Banking Human Samples Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bio-Banking Human Samples Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bio-Banking Human Samples Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bio-Banking Human Samples Market Size & Forecast, 2018-2028
4.5.1 Bio-Banking Human Samples Market Size and Y-o-Y Growth
4.5.2 Bio-Banking Human Samples Market Absolute $ Opportunity
Chapter 5 Global Bio-Banking Human Samples Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bio-Banking Human Samples Market Size Forecast by Type
5.2.1 Population Based Biobank
5.2.2 Disease-Oriented Biobank
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bio-Banking Human Samples Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bio-Banking Human Samples Market Size Forecast by Applications
6.2.1 Biotherapy
6.2.2 Research Institutions
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bio-Banking Human Samples Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bio-Banking Human Samples Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bio-Banking Human Samples Analysis and Forecast
9.1 Introduction
9.2 North America Bio-Banking Human Samples Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bio-Banking Human Samples Market Size Forecast by Type
9.6.1 Population Based Biobank
9.6.2 Disease-Oriented Biobank
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bio-Banking Human Samples Market Size Forecast by Applications
9.10.1 Biotherapy
9.10.2 Research Institutions
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bio-Banking Human Samples Analysis and Forecast
10.1 Introduction
10.2 Europe Bio-Banking Human Samples Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bio-Banking Human Samples Market Size Forecast by Type
10.6.1 Population Based Biobank
10.6.2 Disease-Oriented Biobank
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bio-Banking Human Samples Market Size Forecast by Applications
10.10.1 Biotherapy
10.10.2 Research Institutions
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bio-Banking Human Samples Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bio-Banking Human Samples Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bio-Banking Human Samples Market Size Forecast by Type
11.6.1 Population Based Biobank
11.6.2 Disease-Oriented Biobank
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bio-Banking Human Samples Market Size Forecast by Applications
11.10.1 Biotherapy
11.10.2 Research Institutions
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bio-Banking Human Samples Analysis and Forecast
12.1 Introduction
12.2 Latin America Bio-Banking Human Samples Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bio-Banking Human Samples Market Size Forecast by Type
12.6.1 Population Based Biobank
12.6.2 Disease-Oriented Biobank
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bio-Banking Human Samples Market Size Forecast by Applications
12.10.1 Biotherapy
12.10.2 Research Institutions
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bio-Banking Human Samples Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bio-Banking Human Samples Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bio-Banking Human Samples Market Size Forecast by Type
13.6.1 Population Based Biobank
13.6.2 Disease-Oriented Biobank
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bio-Banking Human Samples Market Size Forecast by Applications
13.10.1 Biotherapy
13.10.2 Research Institutions
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bio-Banking Human Samples Market: Competitive Dashboard
14.2 Global Bio-Banking Human Samples Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Brooks Life Science
14.3.2 Tecan Group
14.3.3 Promega
14.3.4 Hamilton
14.3.5 BD
14.3.6 Merck
14.3.7 DNA Genotek
14.3.8 Biolife Solutions
14.3.9 QIAGEN
14.3.10 Greiner Bio One
14.3.11 Shanghai Genext Medical Techology Co Ltd
14.3.12 TTP Labtech Ltd
14.3.13 BioRep
14.3.14 Beckman Coulter
